VAMP5

There are 3 papers on VAMP5 in aging research: 2 observational studies in people, 1 in cells. The newest story, Nov 3, 2026: “Proteins improved cardiovascular risk prediction in metabolic syndrome”.

Gene

3 papers study it1 finding

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 3 papers on VAMP5

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“higher VAMP5 and NCAN were associated with increased coronary heart disease risk.”
Proteomics assisted improvement prediction of risk for adverse cardiovascular events in individuals with metabolic syndromeBMC cardiovascular disorders2026doi:10.1186/s12872-026-06367-7
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans2
  • Cells1

Associations

1

Coronary artery disease

upin humans1

1 study
  1. VAMP5 is associated with coronary artery disease in humans (Genetically higher protein abundance in two-sample Mendelian randomization).

    “higher VAMP5 and NCAN were associated with increased coronary heart disease risk.”

    HumansGenetically higher protein abundance in two-sample Mendelian randomization

    Proteins improved cardiovascular risk prediction in metabolic syndrome

    BMC cardiovascular disorders

More on Coronary artery disease

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months
BMC Cardiovascular Disorders

Proteins improved cardiovascular risk prediction in metabolic syndrome

A blood-protein model better distinguished who later developed cardiovascular events, scoring 0.730 versus 0.673 for a clinical model in a validation group.A blood-protein model better distinguished who later developed cardiovascular events, scoring 0.730 versus 0.673 for a clinical model in a validation group.

Cohort · 12,308 peopleMetabolic syndrome